ElendiLabs Logo
Back to Articles

Need Regulatory Help? Try Our Platform

Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.

Other

January 17, 2026

Approximately 5 minutes

Digital Nursing Applications (DiPA) in Germany (BfArM)

Digital Nursing Applications (DiPA) in Germany (BfArM)

Digital Nursing Applications (DiPA) were introduced through the Nursing Strengthening Act (Pflegeunterstützungs- und -entlastungsgesetz) and the DiPA Ordinance (DiPAV), extending the successful DiGA model to the long-term care sector. DiPA are CE-marked (MDR Class I) or non-medical digital applications that support insured persons in long-term care insurance with care-relevant needs (e.g., mobility, self-care, cognitive stimulation, social participation). The goal is to improve care quality, relieve caregivers, and promote independent living. Digital Nursing Applications - BfArM

Eligibility and Requirements

To qualify for inclusion in the DiPA directory:

  • Positive care effect must be demonstrated (structural/procedural improvement or relief for care recipients/caregivers).
  • Compliance with data protection (GDPR), IT security (BSI TR-03161), and interoperability standards.
  • User-friendly design, accessibility, and positive benefit-risk profile.
  • For medical DiPA: MDR CE marking (low risk); non-medical DiPA follow similar quality criteria.

Assessment and Inclusion Process

Application and Provisional Inclusion

  • Manufacturer submits application to BfArM with product description, intended use, evidence plan, and preliminary data.
  • BfArM checks formal requirements and basic eligibility within approx. 3 months.
  • Provisional inclusion granted for 12 months allows prescription by care professionals and reimbursement while final evidence is collected.

Final Benefit Assessment

  • During provisional phase, manufacturer provides comparative evidence (e.g., studies, real-world data) proving positive care effect.
  • BfArM evaluates submitted dossier against predefined criteria (care benefit, quality, security).
  • Positive decision leads to permanent directory inclusion and ongoing reimbursement; negative results in removal.

Prescription, Reimbursement, and Access

  • Care professionals (e.g., nurses, physicians in long-term care) prescribe DiPA using directory codes.
  • Long-term care insurance funds reimburse at manufacturer-set price (initial cap, later negotiated).
  • Users access DiPA via app stores or platforms after prescription and approval.

BfArM Responsibilities and Transparency

  • Maintains the public DiPA directory listing approved applications, evidence summaries, and assessment decisions.
  • Publishes guidance, application forms, checklists, and FAQs to support manufacturers.
  • Collaborates with G-BA and long-term care insurance bodies on evaluation standards.

This pathway integrates digital innovations into long-term care, ensuring evidence-based, secure, and reimbursable support for care-dependent individuals and their caregivers in Germany. Digital Nursing Applications - BfArM

Ask Anything

We'll follow up with you personally.

100% response rate • Reply within 7 business days

Your email will not be published. We'll only use it to notify you when we respond.

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550